Search Results - "Luthi‐Carter, Ruth"

Refine Results
  1. 1

    What have we learned from gene expression profiles in Huntington's disease? by Seredenina, Tamara, Luthi-Carter, Ruth

    Published in Neurobiology of disease (01-01-2012)
    “…Abstract The availability of many high-quality genome-wide expression datasets has provided an exciting and unique opportunity to better understand the…”
    Get full text
    Journal Article
  2. 2

    Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease by Guidetti, Paolo, Luthi-Carter, Ruth E., Augood, Sarah J., Schwarcz, Robert

    Published in Neurobiology of disease (01-12-2004)
    “…Huntington's disease (HD), an inherited neurodegenerative disorder, is caused by an abnormal polyglutamine expansion in the huntingtin protein. This genetic…”
    Get full text
    Journal Article
  3. 3

    MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms by Jovicic, Ana, Zaldivar Jolissaint, Julien Francisco, Moser, Roger, Silva Santos, Mariana de Fatima, Luthi-Carter, Ruth

    Published in PloS one (17-01-2013)
    “…Whereas many causes and mechanisms of neurodegenerative diseases have been identified, very few therapeutic strategies have emerged in parallel. One possible…”
    Get full text
    Journal Article
  4. 4

    Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain by Kuhn, Alexandre, Thu, Doris, Waldvogel, Henry J, Faull, Richard L M, Luthi-Carter, Ruth

    Published in Nature methods (01-11-2011)
    “…A computational approach for analysis of gene expression in heterogeneous samples of varying composition is presented. The authors used it to study expression…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Sustained effects of nonallele-specific Huntingtin silencing by Drouet, Valérie, Perrin, Valérie, Hassig, Raymonde, Dufour, Noëlle, Auregan, Gwennaelle, Alves, Sandro, Bonvento, Gilles, Brouillet, Emmanuel, Luthi-Carter, Ruth, Hantraye, Philippe, Déglon, Nicole

    Published in Annals of neurology (01-03-2009)
    “…Objective Huntington's disease (HD) is a fatal autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion in the huntingtin (htt)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation by Seredenina, Tamara, Gokce, Ozgun, Luthi-Carter, Ruth

    Published in PloS one (14-07-2011)
    “…The molecular phenotype of Huntington's disease (HD) is known to comprise highly reproducible changes in gene expression involving striatal signaling genes…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Tubulin and Tubulin Posttranslational Modifications in Alzheimer's Disease and Vascular Dementia by Santiago-Mujika, Estibaliz, Luthi-Carter, Ruth, Giorgini, Flaviano, Kalaria, Raj N, Mukaetova-Ladinska, Elizabeta B

    Published in Frontiers in aging neuroscience (29-10-2021)
    “…Alzheimer's disease (AD) and vascular dementia (VaD) are the two most common forms of dementia in older people. Although these two dementia types differ in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice by Ferrante, Robert J, Kubilus, James K, Lee, Junghee, Ryu, Hoon, Beesen, Ayshe, Zucker, Birgit, Smith, Karen, Kowall, Neil W, Ratan, Rajiv R, Luthi-Carter, Ruth, Hersch, Steven M

    Published in The Journal of neuroscience (15-10-2003)
    “…The precise cause of neuronal death in Huntington's disease (HD) is unknown. Although no single specific protein-protein interaction of mutant huntingtin has…”
    Get full text
    Journal Article
  18. 18

    Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease by Tang, Bin, Seredenina, Tamara, Coppola, Giovanni, Kuhn, Alexandre, Geschwind, Daniel H, Luthi-Carter, Ruth, Thomas, Elizabeth A

    Published in Neurobiology of disease (01-06-2011)
    “…Abstract R6/2 transgenic mice with expanded CAG repeats (> 300) have a surprisingly prolonged disease progression and longer lifespan than prototypical parent…”
    Get full text
    Journal Article
  19. 19

    Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease by McFarland, Karen N, Das, Sudeshna, Sun, Ting Ting, Leyfer, Dmitri, Xia, Eva, Sangrey, Gavin R, Kuhn, Alexandre, Luthi-Carter, Ruth, Clark, Timothy W, Sadri-Vakili, Ghazaleh, Cha, Jang-Ho J

    Published in PloS one (27-07-2012)
    “…In Huntington's disease (HD; MIM ID #143100), a fatal neurodegenerative disorder, transcriptional dysregulation is a key pathogenic feature. Histone…”
    Get full text
    Journal Article
  20. 20

    Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood by Runne, Heike, Kuhn, Alexandre, Wild, Edward J, Pratyaksha, Wirahpati, Kristiansen, Mark, Isaacs, Jeremy D, Régulier, Etienne, Delorenzi, Mauro, Tabrizi, Sarah J, Luthi-Carter, Ruth

    “…Highly quantitative biomarkers of neurodegenerative disease remain an important need in the urgent quest for disease-modifying therapies. For Huntington's…”
    Get full text
    Journal Article